2b37 Citations

High Affinity InhA Inhibitors with Activity against Drug-Resistant Strains of Mycobacterium tuberculosis

Reviews - 2b37 mentioned but not cited (1)

  1. Coumarins and P450s, Studies Reported to-Date. Foroozesh M, Sridhar J, Goyal N, Liu J. Molecules 24 E1620 (2019)

Articles - 2b37 mentioned but not cited (13)

  1. Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis. Kinnings SL, Liu N, Buchmeier N, Tonge PJ, Xie L, Bourne PE. PLoS Comput Biol 5 e1000423 (2009)
  2. A slow, tight binding inhibitor of InhA, the enoyl-acyl carrier protein reductase from Mycobacterium tuberculosis. Luckner SR, Liu N, am Ende CW, Tonge PJ, Kisker C. J Biol Chem 285 14330-14337 (2010)
  3. Structure of acyl carrier protein bound to FabI, the FASII enoyl reductase from Escherichia coli. Rafi S, Novichenok P, Kolappan S, Stratton CF, Rawat R, Kisker C, Simmerling C, Tonge PJ. J Biol Chem 281 39285-39293 (2006)
  4. A structural and energetic model for the slow-onset inhibition of the Mycobacterium tuberculosis enoyl-ACP reductase InhA. Li HJ, Lai CT, Pan P, Yu W, Liu N, Bommineni GR, Garcia-Diaz M, Simmerling C, Tonge PJ. ACS Chem Biol 9 986-993 (2014)
  5. Halogen-π Interactions in the Cytochrome P450 Active Site: Structural Insights into Human CYP2B6 Substrate Selectivity. Shah MB, Liu J, Zhang Q, Stout CD, Halpert JR. ACS Chem Biol 12 1204-1210 (2017)
  6. Structure-Function Analysis of Mammalian CYP2B Enzymes Using 7-Substituted Coumarin Derivatives as Probes: Utility of Crystal Structures and Molecular Modeling in Understanding Xenobiotic Metabolism. Shah MB, Liu J, Huo L, Zhang Q, Dearing MD, Wilderman PR, Szklarz GD, Stout CD, Halpert JR. Mol Pharmacol 89 435-445 (2016)
  7. An Effective Approach for Clustering InhA Molecular Dynamics Trajectory Using Substrate-Binding Cavity Features. De Paris R, Quevedo CV, Ruiz DD, Norberto de Souza O. PLoS One 10 e0133172 (2015)
  8. Phenobarbital induces alterations in the proteome of hepatocytes and mesenchymal cells of rat livers. Klepeisz P, Sagmeister S, Haudek-Prinz V, Pichlbauer M, Grasl-Kraupp B, Gerner C. PLoS One 8 e76137 (2013)
  9. A selective method for optimizing ensemble docking-based experiments on an InhA Fully-Flexible receptor model. De Paris R, Vahl Quevedo C, Ruiz DD, Gargano F, de Souza ON. BMC Bioinformatics 19 235 (2018)
  10. Aqueous Molecular Dynamics Simulations of the M. tuberculosis Enoyl-ACP Reductase-NADH System and Its Complex with a Substrate Mimic or Diphenyl Ethers Inhibitors. da Silva Lima CH, de Alencastro RB, Kaiser CR, de Souza MV, Rodrigues CR, Albuquerque MG. Int J Mol Sci 16 23695-23722 (2015)
  11. Antitubercular activity of 1,2,3-triazolyl fatty acid derivatives. Ghiano DG, de la Iglesia A, Liu N, Tonge PJ, Morbidoni HR, Labadie GR. Eur J Med Chem 125 842-852 (2017)
  12. High throughput metabolomics-proteomics investigation on metabolic phenotype changes in rats caused by Radix Scrophulariae using ultra-performance liquid chromatography with mass spectrometry. Lu F, Zhang N, Ye T, Zhao H, Pang M, Liu SM. RSC Adv 9 17791-17800 (2019)
  13. Identification of novel anti-tuberculosis agent: An in silico investigation. Vasava M, Thacker S, Jethwa D, Acharya P, Bhavsar Z, Patel H. Indian J Tuberc 69 503-522 (2022)